Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

28.28USD
21 Oct 2014
Price Change (% chg)

$0.35 (+1.25%)
Prev Close
$27.93
Open
$28.15
Day's High
$28.51
Day's Low
$28.00
Volume
8,071,208
Avg. Vol
--
52-wk High
--
52-wk Low
--

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.72
Market Cap (Mil.): $177,100.30
Shares Outstanding (Mil.): 6,340.86
Dividend: 0.26
Yield (%): 3.72

Financials

  PFE.N Industry Sector
P/E (TTM): 17.62 32.74 33.38
EPS (TTM): 1.59 -- --
ROI: 6.80 18.26 17.53
ROE: 13.38 18.93 18.34
Search Stocks

FDA panel votes to keep severe warning on Pfizer anti-smoking drug

- Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

16 Oct 2014

UPDATE 1-FDA panel votes to keep severe warning on Pfizer anti-smoking drug

Oct 16 - Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

16 Oct 2014

FDA votes to keep black box warning on Pfizer anti-smoking drug

Oct 16 - Pfizer Inc failed in its attempt to remove a black box warning from its controversial quit-smoking drug, Chantix, after an advisory panel to the U.S. Food and Drug Administration voted against the removal.

16 Oct 2014

Banks could miss out on $135 million fees as Abbvie drops Shire deal

LONDON - A decision by U.S. drugmaker AbbVie to scrap its plans to buy Dublin-based Shire could mean that bankers miss out on up to $135 million in fees linked to the deal.

16 Oct 2014

Wife of convicted ex-SAC employee petitions to keep cash, home

NEW YORK, Oct 15 - A federal judge in Manhattan will soon have to weigh in on how the family of a convicted insider trader should live while the man spends nearly a decade in federal prison.

15 Oct 2014

FDA staff recommend Pfizer keep black box warning on anti-smoking drug

- Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label.

14 Oct 2014

UPDATE 1-FDA staff recommend Pfizer keep black box warning on anti-smoking drug

Oct 14 - Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label.

14 Oct 2014

FDA staff wants Pfizer to keep black box warning on anti-smoking drug

Oct 14 - U.S. Food and Drug Administration staff recommended that Pfizer Inc keep a severe warning on its controversial quit-smoking drug Chantix.

14 Oct 2014

Impax Labs on the hunt after striking two deals worth $700 million

- Impax Laboratories Inc said it was on the hunt for further deals - and would consider a so-called "tax inversion" transaction - after its acquisition of two privately held Pennsylvania drugmakers for $700 million.

09 Oct 2014

CORRECTED-UPDATE 1-Impax buys anti-allergy injection makers for $700 mln

(Corrects paragraph 5 to say the EpiPen is produced my Mylan Inc, not Pfizer Inc)

09 Oct 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $100.36 +1.16
Novartis AG (NOVN.VX) CHF83.55 +0.75
Merck & Co., Inc. (MRK.N) $55.13 +1.08
Roche Holding Ltd. (ROG.VX) CHF274.70 +6.10
Abbott Laboratories (ABT.N) $42.39 +0.93
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €81.48 +1.05
AstraZeneca plc (AZN.L) 4,235.50p +66.00
GlaxoSmithKline plc (GSK.L) 1,342.00p +3.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks